Research location

Upland

Pennsylvania, United States

Published trials104
Site observations104
Linked trials published104
Page1 / 3
Advertisement

Research activity in Upland

Pennsylvania, United States

CureCurrent currently publishes aggregate city-level research activity for this location: 104 trials and 104 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Upland

104 linked trials · page 1 of 3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])NCT04267848 · 2020-06-16 · 1 site observation
RECRUITING
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD TrialNCT04457596 · 2021-03-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialNCT04134260 · 2020-04-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast CancerNCT03199885 · 2019-04-05 · 1 site observation
TERMINATED
Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung CancerNCT02566993 · 2016-08-30 · 1 site observation
COMPLETED
SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)NCT02643420 · 2016-01-19 · 1 site observation
COMPLETED
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma ControlNCT02281318 · 2014-12-11 · 1 site observation
COMPLETED
Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent AsthmaNCT02139644 · 2014-06-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent AsthmaNCT02141854 · 2014-06-01 · 1 site observation
COMPLETED
A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric AsthmaticsNCT02126839 · 2014-05-01 · 1 site observation
COMPLETED
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μgNCT02091986 · 2014-04-01 · 1 site observation
COMPLETED
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerNCT01674140 · 2013-09-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller MedicationNCT01868061 · 2013-07-31 · 1 site observation
COMPLETED
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled AsthmaNCT01854047 · 2013-06-01 · 1 site observation
COMPLETED
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator ReversibilityNCT01902290 · 2013-05-22 · 1 site observation
TERMINATED
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerNCT01547741 · 2012-04-01 · 1 site observation
COMPLETED
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma MedicationsNCT01576718 · 2012-04-01 · 1 site observation
COMPLETED
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)NCT01545440 · 2012-03-01 · 1 site observation
COMPLETED
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing SteroidsNCT01479621 · 2012-01-01 · 1 site observation
COMPLETED
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of AsthmaNCT01472757 · 2011-10-01 · 1 site observation
COMPLETED
A Safety and Efficacy Study of Tralokinumab in Adults With AsthmaNCT01402986 · 2011-08-01 · 1 site observation
COMPLETED
Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) TherapyNCT01397162 · 2011-07-21 · 1 site observation
TERMINATED
Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).NCT01396278 · 2011-07-01 · 1 site observation
TERMINATED
Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)NCT01397201 · 2011-07-01 · 1 site observation
TERMINATED
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma PatientsNCT01357642 · 2011-07-01 · 1 site observation
COMPLETED
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by SurgeryNCT01349322 · 2011-05-24 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic AsthmaNCT01312961 · 2011-03-01 · 1 site observation
COMPLETED
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerNCT01272037 · 2011-02-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerNCT01275677 · 2011-02-08 · 1 site observation
COMPLETED
Efficacy, Safety, and Pharmacokinetics of QAW039NCT01253603 · 2010-11-01 · 1 site observation
COMPLETED
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating EfficacyNCT01136655 · 2010-09-01 · 1 site observation
COMPLETED
A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus InfectionNCT01175226 · 2010-08-01 · 1 site observation
COMPLETED
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With PlaceboNCT01136382 · 2010-07-01 · 1 site observation
COMPLETED
A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term TherapyNCT01125748 · 2010-05-01 · 1 site observation
COMPLETED
JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With NatalizumabNCT01070836 · 2010-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Different Doses of IndacaterolNCT01079130 · 2010-02-01 · 1 site observation
COMPLETED
Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)NCT00970268 · 2009-08-01 · 1 site observation
COMPLETED
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyNCT00858364 · 2009-07-17 · 1 site observation
TERMINATED
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung CancerNCT00946712 · 2009-07-15 · 1 site observation
TERMINATED
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast CancerNCT00881361 · 2009-07-01 · 1 site observation
COMPLETED
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerNCT00887536 · 2009-05-01 · 1 site observation
COMPLETED
Study of Immunotherapy to Treat Advanced Prostate CancerNCT00861614 · 2009-05-01 · 1 site observation
COMPLETED
A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary DiseaseNCT00862641 · 2009-04-01 · 1 site observation
COMPLETED
Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)NCT00891462 · 2009-04-01 · 1 site observation
COMPLETED
A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIALNCT00801853 · 2009-03-01 · 1 site observation
COMPLETED
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone LumpectomyNCT00769379 · 2008-12-10 · 1 site observation
COMPLETED
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With AsthmaNCT00809757 · 2008-12-01 · 1 site observation
COMPLETED
4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe AsthmaNCT00818454 · 2008-12-01 · 1 site observation
COMPLETED
A Phase 2a Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Adults With AsthmaNCT00783289 · 2008-11-14 · 1 site observation
COMPLETED
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerNCT00785291 · 2008-10-13 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.